Phibro Animal Health Corporation
Phibro Animal Health Corporation (PAHC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · PAHC · as of Sep 30, 2025
Ownership Breakdown
220
Institutional Holders
▲ 26 vs Q2
$793.25M
Total Inst. Value
▲ $271.92M vs Q2
40.54M
Shares Outstanding
freeFloat 99.26%
19.61M
13F Shares Held
▼ 806,516 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
PAHC largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 3.43M | 8.46% | 8.46% | $138.62B | Nov 12, 2025 | ▼ 65.2K |
VANGUARD GROUP INC pharmaceutical preparations | 1.53M | 3.77% | 3.77% | $61.73B | Nov 7, 2025 | ▼ 22.5K |
STATE STREET CORP pharmaceutical preparations | 894.0K | 2.21% | 2.21% | $36.17B | Nov 14, 2025 | ▼ 15.3K |
ACADIAN ASSET MANAGEMENT LLC pharmaceutical preparations | 785.8K | 1.94% | 1.94% | $31.78B | Nov 13, 2025 | ▲ 61.4K |
FMR LLC pharmaceutical preparations | 597.6K | 1.48% | 1.48% | $24.18B | Nov 13, 2025 | ▲ 538.0K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 555.2K | 1.37% | 1.37% | $22.46B | Nov 13, 2025 | ▼ 55.6K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 547.2K | 1.35% | 1.35% | $22.14B | Nov 12, 2025 | ▼ 7.8K |
DIMENSIONAL FUND ADVISORS LP pharmaceutical preparations | 485.5K | 1.20% | 1.20% | $19.64B | Nov 12, 2025 | ▼ 71.7K |
NUVEEN, LLC pharmaceutical preparations | 479.2K | 1.18% | 1.18% | $19.39B | Nov 12, 2025 | ▲ 19.5K |
MORGAN STANLEY pharmaceutical preparations | 436.0K | 1.08% | 1.08% | $17.64B | May 27, 2026 | ▼ 55.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
20
Increased
+1.33M shares5
New Positions
first time holders25
Decreased
−897.3K shares0
Sold Out
fully exitedNet shares change (top 50)
+437.5K
+1.33M / −897.3K
Net new holders
+0
5 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
PAHC insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
27
Sell transactions
0.04
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
CORCORAN E THOMAS director | May 29, 2026 | Purchase | 10,000 | $31.77 | $317.7K | 41.5K | Form 4 ↗ |
BENDHEIM JACK President and CEO | May 5, 2026 | Sale | 6,264 | $55.73 | $349.1K | 68.5K | Form 4 ↗ |
BENDHEIM JACK President and CEO | May 5, 2026 | Sale | 776 | $56.37 | $43.7K | 67.7K | Form 4 ↗ |
BENDHEIM JACK President and CEO | May 6, 2026 | Sale | 5,634 | $57.18 | $322.1K | 62.1K | Form 4 ↗ |
BENDHEIM JACK President and CEO | May 6, 2026 | Sale | 1,406 | $58.13 | $81.7K | 60.7K | Form 4 ↗ |
BENDHEIM JACK President and CEO | May 7, 2026 | Sale | 1,350 | $47.59 | $64.2K | 59.3K | Form 4 ↗ |
BENDHEIM JACK President and CEO | May 7, 2026 | Sale | 1,149 | $48.31 | $55.5K | 58.2K | Form 4 ↗ |
BENDHEIM JACK President and CEO | May 7, 2026 | Sale | 2,029 | $49.19 | $99.8K | 56.2K | Form 4 ↗ |
BENDHEIM JACK President and CEO | Apr 28, 2026 | Sale | 1,652 | $55.10 | $91.0K | 94.2K | Form 4 ↗ |
BENDHEIM JACK President and CEO | Apr 28, 2026 | Sale | 4,591 | $56.06 | $257.4K | 89.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Phibro Animal Health Corporation (PAHC) is primarily owned by institutional investors, who hold approximately 48.4% of total shares outstanding. Company insiders own approximately 0.74%, while retail and public investors account for the remaining 50.90%.
The largest institutional shareholder of Phibro Animal Health Corporation is BLACKROCK, INC., holding approximately 3.43 million shares — equal to 8.46% of outstanding shares — as of September 30, 2025.
A total of 220 institutional investors currently hold PAHC stock, with a combined institutional value of approximately $793,245,490 as of the most recent 13F filing period.
Frequently asked questions
PAHC ownershipPhibro Animal Health Corporation (PAHC) is primarily owned by institutional investors, who hold approximately 48.4% of shares. The largest shareholder is BLACKROCK, INC. with a 8.46% stake. Company insiders hold 0.74%. Data sourced from SEC Form 13F as of September 30, 2025.